Investment Job Creation Active Pharmaceutical Ingredients Drug Development Domestic Production Drug Production Facilities Safety Protocols Safety Regulations Labor Relations Pharmaceutical Manufacturing Quality Assurance Safety Standards Excipients Pharmaceutical Excipients Tariffs Supply Chain Biomanufacturing Production-Linked Incentive Scheme Quality Control Regulatory Affairs Production Processes Generics U.S. Operations Economic Development Biotechnology Drug Manufacturing Biopharmaceuticals Reshoring Contract Manufacturing Cough Syrups Differentiated Formulations Life Sciences Pharmaceutical Formulations Eli Lilly Compliance Issues Investments Biologics Sudeep Pharma Pharmaceutical Ingredients Acquisitions Specialty Ingredients International Collaboration Production Sites Product Control Production Issues Trade Policies Environmental Issues RayzeBio Inc Global Trade Local Production Factory Operations Trade Medical Supplies Production Facilities Chemical Processing Workplace Safety Assembly and Packaging U.S. Manufacturing
State incentives worth up to $105 million helped secure the site to boost U.S. capacity.
